Product Information

VALGANCICLOVIR 450 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $1.8828 per EA under NDC 64380016101. Its NADAC has been published 44 times since Aug 27, 2025.

The High Outlier badge above means this manufacturer's average price in the Valganciclovir hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

VALGANCICLOVIR 450 MG TABLET

Valganciclovir hydrochloride
$1.8828per EA
High Outlier

Strength

450 mg/1

NDC

64380016101

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200790

On Market Since

6/16/2025

Pharmacological Classes

Price Statistics

The NADAC for VALGANCICLOVIR 450 MG TABLET has been published 44 times since Aug 27, 2025, and over the history we have for it it has declined 24.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8828 per EA
All-time high$2.5006 (Nov 12, 2025)
All-time low$1.8426 (May 20, 2026)
52-week high$2.5006
52-week low$1.8426
Median price$2.0000
Average price$2.1455
Largest weekly change-8.0% (Jan 21, 2026)
Weeks tracked44
Tracking sinceAug 27, 2025

Price History

1W

0.0%

1M

+2.2%

3M

-3.0%

6M

-13.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-24.1%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of VALGANCICLOVIR 450 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VALGANCICLOVIR 450 MG TABLET, manufactured by Strides Pharma Inc., is $1.8828 per EA (NDC 64380016101), effective Jun 24, 2026.

How has the price of VALGANCICLOVIR 450 MG TABLET changed over time?

Over the history we have for it, the NADAC for VALGANCICLOVIR 450 MG TABLET has declined 24.1%. It has been tracked across 44 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for VALGANCICLOVIR 450 MG TABLET?

Since Aug 27, 2025, the NADAC for VALGANCICLOVIR 450 MG TABLET has ranged from a low of $1.8426 (May 20, 2026) to a high of $2.5006 (Nov 12, 2025), with a median of $2.0000 per EA.

Are there cheaper alternatives to VALGANCICLOVIR 450 MG TABLET?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as VALGANCICLOVIR 450 MG TABLET, but none are currently priced below it.

Who manufactures VALGANCICLOVIR 450 MG TABLET?

VALGANCICLOVIR 450 MG TABLET (NDC 64380016101) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.